Literature DB >> 22614029

Patient positioning variations to reduce dose to normal tissues during 3D conformal radiotherapy for high-risk prostate cancer.

K Czigner1, P Agoston, G Forgács, M Kásler.   

Abstract

BACKGROUND AND
PURPOSE: The goal of this work was to assess optimal treatment positioning of 3D conformal radiotherapy (3DCRT) for high-risk prostate cancer patients. PATIENTS AND METHODS: Treatment plans of 25 patients in different patient positions were evaluated: with knee and ankle support (KAS) in the supine position and with a belly board (BB) in the prone position both with full (FB) and empty bladder (EB). Planning target volumes (PTVs) for pelvis, prostate and vesicles, prostate, and organs at risk (OARs) were delineated. Dose and overlapping volumes were evaluated.
RESULTS: Overlapping volumes were significantly smaller with a FB than with an EB. No significant differences were found in overlapping volumes with respect to patient fixation systems, but the percentage values of dose to the OARs showed significantly better results employing KAS than a BB. A FB reduced the dose volumes to the OARs. Comparison with respect to circumference of abdomen (CA) showed significantly smaller overlapping at large CA in most of the cases.
CONCLUSION: Supine position is suggested with KAS combined with a FB (especially in cases of larger CA) when using 3DCRT with planning technique modification for high-risk prostate cancer patients to reduce the dose of OARs, based on our results.

Entities:  

Mesh:

Year:  2012        PMID: 22614029     DOI: 10.1007/s00066-012-0126-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  30 in total

1.  A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.

Authors:  Andrea Hille; Nadja Töws; Heinz Schmidberger; Clemens F Hess
Journal:  Strahlenther Onkol       Date:  2005-12       Impact factor: 3.621

2.  The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy.

Authors:  M J Zelefsky; L Happersett; S A Leibel; C M Burman; L Schwartz; A P Dicker; G J Kutcher; Z Fuks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-01-01       Impact factor: 7.038

3.  An evaluation of intrafraction motion of the prostate in the prone and supine positions using electromagnetic tracking.

Authors:  Amish P Shah; Patrick A Kupelian; Twyla R Willoughby; Katja M Langen; Sanford L Meeks
Journal:  Radiother Oncol       Date:  2011-03-30       Impact factor: 6.280

4.  The effect of patient position and treatment technique in conformal treatment of prostate cancer.

Authors:  P W McLaughlin; A Wygoda; W Sahijdak; H M Sandler; L Marsh; P Roberson; R K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

5.  Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer.

Authors:  Michael Pinkawa; Marc D Piroth; Richard Holy; Victoria Djukic; Jens Klotz; Barbara Krenkel; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2011-07-25       Impact factor: 3.621

6.  Dose response in prostate cancer with 8-12 years' follow-up.

Authors:  Gerald E Hanks; Alexandra L Hanlon; Barry Epstein; Eric M Horwitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-10-01       Impact factor: 7.038

7.  Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.

Authors:  Jeff M Michalski; Kyounghwa Bae; Mack Roach; Arnold M Markoe; Howard M Sandler; Janice Ryu; Matthew B Parliament; William Straube; Richard K Valicenti; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

8.  Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

Authors:  M J Zelefsky; S A Leibel; P B Gaudin; G J Kutcher; N E Fleshner; E S Venkatramen; V E Reuter; W R Fair; C C Ling; Z Fuks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-06-01       Impact factor: 7.038

9.  A comparison of prone three-dimensional conformal radiotherapy with supine intensity-modulated radiotherapy for prostate cancer: which technique is more effective for rectal sparing?

Authors:  T Kato; Y Obata; N Kadoya; N Fuwa
Journal:  Br J Radiol       Date:  2009-03-30       Impact factor: 3.039

10.  A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation.

Authors:  M J Gallagher; H D Brereton; R A Rostock; J M Zero; D A Zekoski; L F Poyss; M P Richter; M M Kligerman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-09       Impact factor: 7.038

View more
  4 in total

1.  Does transperitoneal minimally invasive radical prostatectomy increase the amount of small bowel receiving salvage radiation?

Authors:  Murilo A Luz; Alan Dal Pra; Hin-Yu Vincent Tu; Marie Duclos; Fabio L B Cury; Bassel G Bachir; Armen G Aprikian; Simon Tanguay; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

2.  Three-dimensional surface scanning for accurate patient positioning and monitoring during breast cancer radiotherapy.

Authors:  C Gaisberger; P Steininger; B Mitterlechner; S Huber; H Weichenberger; F Sedlmayer; H Deutschmann
Journal:  Strahlenther Onkol       Date:  2013-06-07       Impact factor: 3.621

3.  Interfractional variability in intensity-modulated radiotherapy of prostate cancer with or without thermoplastic pelvic immobilization.

Authors:  J A Lee; C Y Kim; Y J Park; W S Yoon; N K Lee; D S Yang
Journal:  Strahlenther Onkol       Date:  2013-11-08       Impact factor: 3.621

4.  Volumetric and dosimetric comparison of organs at risk between the prone and supine positions in postoperative radiotherapy for prostate cancer.

Authors:  Subaru Sawayanagi; Hideomi Yamashita; Mami Ogita; Tomoki Kiritoshi; Takahiro Nakamoto; Osamu Abe; Keiichi Nakagawa
Journal:  Radiat Oncol       Date:  2018-04-17       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.